Limiting Federal Agencies' Authority Over Medical Practice and Drug Use.
This Act aims to restrict the authority of federal agencies, such as the FDA and CDC, from regulating the practice of medicine. This means physicians would gain greater freedom in prescribing approved drugs for uses other than those originally approved (known as off-label use). For citizens, this could translate into broader access to treatments that their doctor deems appropriate, without needing additional federal approvals.
Key points
Federal agencies (including FDA and NIH) lose the authority to regulate the practice of medicine itself, increasing physician autonomy.
Physicians can freely prescribe approved drugs for unapproved uses (off-label use) without federal prohibitions or restrictions.
The Act does not affect federal laws restricting abortion, assisted suicide, euthanasia, or gender transition medical interventions.
Expired
Additional Information
Print number: 118_S_5481
Sponsor: Sen. Johnson, Ron [R-WI]
Process start date: 2024-12-11